Iindaba

I-RD13-02 yimveliso yeseli ye-CAR-T ejolise kwi-CD7 evela kubanikeli abaphilileyo, kwaye yenzelwe ukunyanga i-T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) ephinde yafunyanwa okanye enganyangekiyo. Iguqulwe ngokwemfuza ukuze kuthintelwe i-fratricide, isifo se-graft-versus-host (GvHD), kunye ne-host-versus-...Funda ngokugqithisileyo»

I-CT011 yimveliso ye-GPC3 CAR T-cell ekhethiweyo yonyango lwe-hepatocellular carcinoma (HCC). I-CT011 yafumana imvume ye-IND kwi-NMPA ngo-2019 yokunyanga izigulana ezine-GPC3-positive solid tumor eyayiyeyona mvume yokuqala yaseTshayina yonyango lwe-CAR T-cell nxamnye ne-solid ...Funda ngokugqithisileyo»

Unjingalwazi weyunivesithi yaseRashiya okwiminyaka yakhe yokugqibela engamashumi asixhenxe unesifo esiphambili se-multiple myeloma. Emva kokufumana unyango oluninzi kunye nokufakelwa i-autologous kabini, wafunda ngonyango oluphambili lokulwa nomhlaza i-CAR-T eTshayina, ngoko ke weza eTshayina ukuze afumane i-CAR-T cell...Funda ngokugqithisileyo»

Ngomhla wama-20 kuJulayi, iSicelo esitsha seDrug (NDA) se-pCAR-19B esaphuhliswa ngokuzimeleyo yiPrecision Biology samkelwa ngokusesikweni yi-China National Medical Products Administration (NMPA). Le mveliso yimveliso yokuqala ye-CAR-T ye-leukemia yabantwana e-China, esetyenziselwa ukunyanga izigulana ezineminyaka emi-3 ukuya kwengama-21 ubudala ...Funda ngokugqithisileyo»

I-satricabtagene autoleucel (Satri-cel, CT041) yimveliso ye-CAR T-cell ekhethiweyo xa ithelekiswa neproteni yeClaudin18.2 enokuba yeyokuqala kwihlabathi liphela. I-Satri-cel ijolise kwiClaudin18.2 solid tumors egxile kakhulu kumhlaza wesisu/umhlaza we-gastroesophageal junction...Funda ngokugqithisileyo»

Ngomhla wesi-6 kweyoMsintsi, ngo-2021, i-JW Therapeutics ibhengeze ukuba i-National Medical Products Administration (NMPA) yaseTshayina ivumile i-New Drug Application (NDA) ye-anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product relmacabtagene autoleucel injection (relma-cel) ...Funda ngokugqithisileyo»

I-Equecabtagene autoleucel (eque-cel), unyango lwe-T-cell oluvela kubantu oluvela kwi-B-cell maturation antigen-targeting chimeric antigen receptor (CAR), lubonakalise amandla okunyanga i-relapse okanye i-refractory multiple myeloma (R/RMM). Ngomhla wama-30 kuJuni, ngo-2023, i-National Medical Products Admi...Funda ngokugqithisileyo»

Ngomhla we-11 kweyeDwarha ngo-2024, i-National Medical Product Administration (NMPA) yaseTshayina ivumile isicelo se-Investigational New Drug (IND) se-Inaticabtagene Autoleucel (CNCT19 Injection), unyango lweeseli ze-antigen receptor (CAR)-T ezijoliswe kwi-CD19, ukunyanga i-Immune thrombocytopenia ...Funda ngokugqithisileyo»

Ngomhla woku-1 kweyoKwindla, ngowama-2024, i-China National Medical Products Administration (NMPA) yavuma ukuqaliswa kwemveliso yeseli ye-CAR-T iZevorcabtagene AutoLeucel (Zevor-cel, CT053) kunyango lwabantu abadala abane-myeloma ephinde yabuyela kwisimo sayo okanye enganyangekiyo abaye baqhubeka emva kweendlela ezintathu zonyango (...Funda ngokugqithisileyo»

I-Clustered regularly interspaced short palindromic repeats (CRISPR) yindlela yokuhlela i-genome yesizukulwana sesithathu eye yaguqula ihlabathi ngeziphumo zayo eziphezulu. Isetyenziselwe ukunyanga izifo ezahlukeneyo zebhayoloji kunye nosulelo. Iibhaktheriya ezahlukeneyo...Funda ngokugqithisileyo»

Ityala 1: Isigulana esiyindoda esineminyaka engama-69 ubudala siye esibhedlele ukuze sihlolwe ngenxa yentlungu yesifuba. Ngelishwa, sasinesifo se-squamous cell carcinoma esincinci esibonakalayo somphunga ongaphezulu ngasekunene. Isigulana sasingakwazi ukunyamezela utyando. Emva kokubonisana neengcali, i-cryoablation yayiyeyona ndlela ilungileyo yokusombulula ingxaki...Funda ngokugqithisileyo»

UCryoablation: "Iindaba ezimnandi" kwizigulana ezineethumba eziqinileyo kwiindawo ezahlukeneyo zomzimba Inkwenkwezi yefilimu edumileyo yaseHong Kong uWu MengDa usweleke ngenxa yomhlaza wesibindi, ukuhamba kukaMalume uDa kubangele ukuba abantu abaninzi bazisole. "Umhlaza wesibindi" wawusaziwa njengokumkani womhlaza, kwaye ama-70% esibindi ...Funda ngokugqithisileyo»